1. Academic Validation
  2. Angiopoietin-like 4 is upregulated by amphiregulin and activates cell proliferation and migration through p38 kinase in head and neck squamous cell carcinoma

Angiopoietin-like 4 is upregulated by amphiregulin and activates cell proliferation and migration through p38 kinase in head and neck squamous cell carcinoma

  • J Oral Pathol Med. 2024 May 19. doi: 10.1111/jop.13545.
Ajay Kumar 1 Emmanuel Asiedu 1 Eman Hefni 1 2 Cheryl Armstrong 1 Deepak Menon 1 Tao Ma 1 Lauren Sands 1 Eberechi Mbadugha 1 Akrit Sodhi 3 Abraham Schneider 1 4 Silvia Montaner 1 4
Affiliations

Affiliations

  • 1 Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, USA.
  • 2 Department of Basic and Clinical Oral Sciences, College of Dental Medicine, Umm Al Qura University, Makkah, Saudi Arabia.
  • 3 Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • 4 Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland, USA.
Abstract

Background: Angiopoietin-like 4 is a molecular hallmark that correlates with the growth and metastasis of head and neck squamous cell carcinoma, one of the most prevalent cancers worldwide. However, the molecular mechanisms by which angiopoietin-like 4 promotes head and neck squamous cell carcinoma tumorigenesis are unclear.

Methods: Using well-characterized cell lines of head and neck squamous cell carcinoma development, including human normal oral keratinocytes, dysplastic oral keratinocytes, oral leukoplakia-derived oral keratinocytes, and head and neck squamous cell carcinoma cell lines, HN13, HN6, HN4, HN12, and CAL27, we investigated the signaling pathways upstream and downstream of angiopoietin-like 4-induced head and neck squamous cell carcinoma tumorigenesis.

Results: We found that both epidermal growth factor receptor ligands, epithelial growth factor, and Amphiregulin led to angiopoietin-like 4 upregulation in normal oral keratinocytes and dysplastic oral keratinocytes and cooperated with the activation of hypoxia-inducible factor-1 in this effect. Interestingly, Amphiregulin and angiopoietin-like 4 were increased in dysplastic oral keratinocytes and head and neck squamous cell carcinoma cell lines, and amphiregulin-induced activation of cell proliferation was dependent on angiopoietin-like 4. Although both p38 mitogen-activated protein kinases (p38 MAPK) and protein kinase B (Akt) were activated by angiopoietin-like 4, only pharmacological inhibition of p38 MAPK was sufficient to prevent head and neck squamous cell carcinoma cell proliferation and migration. We further observed that angiopoietin-like 4 promoted the secretion of interleukin 11 (IL-11), interleukin 12 (IL-12), interleukin-1 alpha (IL-1α), vascular endothelial growth factor, platelet-derived growth factor (PDGF), and tumour necrosis factor alpha (TNF-α), cytokines and chemokines previously implicated in head and neck squamous cell carcinoma pathogenesis.

Conclusion: Our results demonstrate that angiopoietin-like 4 is a downstream effector of Amphiregulin and promotes head and neck squamous cell carcinoma development both through direct activation of p38 kinase as well as paracrine mechanisms.

Keywords

amphiregulin; angiopoietins; carcinogenesis; epidermal growth factor; squamous cell carcinoma of head and neck.

Figures
Products